Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

PARTICIPATING COMPANIES

Companies participating at BioPharm America 2022 to date.

United States

3SBio Inc.

Spain

53Biologics

China

Abbisko

United States

AbbVie

Australia

Acclime Australia

United States

Aditum Bio

France

Adocia Inc

United States

Aenova

United States

Agenus Inc.

United States

Agilent Technologies Inc

Germany

AiCuris Anti-infective Cures AG

United Kingdom

Albumedix

Canada

Altus Formulation Inc.

United States

Alykomed Global Solutions LLC

Sweden

AlzeCure Pharma AB

United States

Amaro Therapeutics, Inc.

United States

Ampel BioSolutions

South Korea

AMTIXBIO CO., LTD.

United States

Apeloa

China

ApicHope Pharmaceutical

Spain

aptaTargets

United States

ARENSIA Exploratory Medicine Inc.

United States

Ascendia Pharmaceuticals, Inc.

Japan

Ascent Development Services

United States

Astellas Pharma Inc.

United States

Astellas Venture Management LLC

United States

Asymchem, Inc.

United States

Attivare Therapeutics

Switzerland

Avance (formerly Whale Bay)

United States

Avance Clinical

South Korea

Avelos Therapeutics

United States

Avistone

United States

AVROBIO

United States

Axter Therapeutics

United States

Azurity Pharmaceuticals

Singapore

Banner Enterprise Pte Ltd

United States

Basel Area Buisness & Innovation

United States

Benchmark Company

United States

Beyond Next Ventures

South Korea

BeyondBio Inc

United Kingdom

Bidwells

United States

Bilayer Therapeutics, Inc.

United States

BIO

United States

Bio 9 Ventures

India

Bio Ideations

United States

BioAdvance

United States

Biocytogen PharmaceuticalsBeijingCo., Ltd.

Taiwan, China

BioEngine Capital

United States

BioEngine Technology Development Inc.

Israel

BioLIneRx Ltd.

Mexico

Bioresearch de México

United States

bioSeedin

United States

Bio-Thera Solutions

United Arab Emirates

Bioventure FZ-LLC

United States

bit.bio

United States

BL&H USA LLC

Austria

Blue Sky Immunotherapies GmbH

United States

Blumberg Institute/HatchBio Func

United States

Boehringer Ingelheim

United States

BOHE

United States

BOKO Therapeutics Inc.

United States

Boston BioConsulting, LLC

United Kingdom

Boyds Consulting

United States

BriOri BioTech

United States

Brown University

United States

Business France

France

CALIXAR

South Korea

CanariaBio Inc.

United States

Capital Family Office

Switzerland

Carthagenetics Suisse Srl

Lithuania

CasZyme

United States

Catalytic Impact Foundation

United States

Cellectar Biosciences Inc

Sweden

Cellevate

United States

Cellino

United States

Centessa Pharmaceuticals

United States

Cerebral

United States

Cerevel Therapeutics

United States

Champions Oncology

United States

Charles River Labs

United States

ChemScene LLC

United States

Chiima Therapeutics

China

China Medical System Holdings

Japan

Chiome Bioscience Inc

United States

Citeline

United States

CLI NY LLC

United States

ColonaryConcepts, LLC

United States

Comera Life Sciences, Inc.

South Korea

Connext

Japan

Corundum Systems Biology Inc.

United States

CR Ventures

Japan

CSB

United States

CureMeta

United States

Cx Precision Medicine

Israel

CytoReason

South Korea

Daewoong Pharmaceutical Co., Ltd.

United States

Daiichi Sankyo Inc

United States

Design Pharmaceuticals Inc

Italy

Digital Networks PLC srl

Spain

DIVERSA Technologies SL

France

DOMAIN THERAPEUTICS

United Kingdom

Domainex

Germany

Dr. Falk Pharma GmbH

United States

Dragon Gate Investment Partners

United States

DSI

China

Duality Biologics

Japan

EA Pharma Co., Ltd.

United States

EBD Group

United States

Eisai Innovation Inc

Israel

Ela Pharma ltd

United States

ElevateBio

United States

Elevian, Inc.

United States

EMD Serono / Merck KGaA, Darmstadt, Germany

United States

Enable Injections

India

Enzene Biosciences Limited

South Korea

ENZYCHEM LIFESCIENCES

Australia

EpiAxis Therapeutics

Belgium

Epics Therapeutics

Japan

e-Projection K.K.

United States

Equitos Venture Partners

United States

Evolution Life Science Partners

South Korea

ExoStemTech

Argentina

FAB / UB / USAL

United States

Fast Track Initiative, Inc.

United States

Fifth Third Bank

France

Firalis

United States

First Star Ventures

United States

Foley Hoag LLP

United States

Fortress Biotech

United States

Fortunatus Capital

United States

FreeMind Group

United States

FreeMind Investments

China

FRONTIER BIOTECHNOLOGIES Inc.

Hungary

FurureDiagnostics.net

Japan

Gemseki Inc.

United States

Generian

United States

GeneScience Pharmaceutical Co., Ltd

United States

GenVault

United States

Ginkgo Bioworks

Italy

GnosisbyLesaffre

United States

GRO Biosciences

China

Haisco Pharmaceutical Group Co., Ltd.

Canada

HDAX Therapeutics

United States

HDT Bio Corp.

United States

Headland Strategy Group, LLC

United States

Health Innovation Capital

China

HitGen Inc.

United Kingdom

Hobson Prior

United States

Hongjing Capital

United States

Honorary Consulate of Latvia in MA

Canada

HTuO Biosciences

United Kingdom

HungaroTrial CRO

United States

Hyloris Pharmaceuticals

Italy

IAMA Therapeutics

United States

ICON plc

United States

Idience Co., Ltd.

Germany

IGES Institut

South Korea

Ildong Pharmaceutical

France

Ilonov

Singapore

IMAPAC

United States

Immetas Therapeutics

China

ImmuneOnco Biopharmaceuticals

United States

ImmunoMet Therapeutics

United States

Immunophotonics, Inc.

Taiwan, China

Immunwork

Italy

indaco venture partners sgr

China

InnoMaitra Therapeutics Inc.

United States

Innovaccer Inc

Germany

INOGROUP

United States

Inova

France

Inovotion

United Kingdom

IN-PART

United States

InstantGMP, Inc.

United Kingdom

Intelligent OMICS Ltd

United States

InvestHK. Hong Kong

United States

Invictus BioPharm

China

InxMed

United States

Ipsen Biosciences

United States

IQVIA

United States

Jaguar Health

United States

Jene Advisors and Capital Management

United States

JETRO

United States

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

China

Jianmin Group

United States

Johnson & Johnson Development Corp, JJDC

United States

JT Pharma

United States

Jubilant Therapeutics

United States

Kairos Bioconsulting LLC

United States

Karuna Therapeutics

United States

Karyopharm Therapeutics

United States

Kintara Therapeutics

Canada

KisoJi Biotechnology Inc.

United States

KISSEI AMERICA, INC.

United States

KLUS Pharma

United States

Korro Bio

South Korea

KP Biosciences, Inc.

Canada

KreaMedica Inc.

United States

Krystal BioTech, Inc.

United States

Ladenburg Thalmann

United States

Laekna Therapeutics

United States

LatchBio

France

Leads To Development

United States

Leapfrog Bio

Netherlands

Liberi Group

United States

Lightchain Capital, LLC

United States

Likarda, LLC

Australia

Linear Clinical Research

Germany

Lingmed Limited

Germany

Lipotype

Latvia

LongeVC

United States

Maculus Therapeutix, Inc.

United States

Madera Therapeutics

Austria

Marinomed Biotech AG

United States

Maruho co. ltd

United States

Marwood Group

United States

Massachusetts Life Sciences Center

United States

Maxwell Biosciences

United States

Mayewell Capital

United States

MD Anderson

United States

MedGene Therapeutics

Canada

Med-Life Discoveries

United States

MelliCell, Inc

United States

Mellitus LLC

Italy

Menarini Group

United States

Merck & Co., Inc.

United States

Merlin Biotech, Inc.

United States

MetaCell LLC

United Kingdom

Metrion Biosciences

Switzerland

MetrioPharm AG

United States

Mid Atlantic Bio Angels

South Korea

Mirae Asset Capital

Japan

Mitsui & Co. Global Investment, Inc.

United States

Model Medicines

United States

MP HEALTHCARE VENTURE MANAGEMENT INC

United States

MRL Venture Funds at Merck

United Kingdom

Multiomic Health

Canada

My Intelligent Machines

Taiwan, China

Mycenax Biotech Inc.

Japan

Myoridge Co. Ltd.

Germany

Navigo Proteins

United States

NDA Group

United States

Ndal Mfg Inc

Italy

Neopharmed Gentili S.p.a.

United States

Netherlands Innovation Network

United States

New rhein healthcare

United States

NextRNA Therapeutics

United States

Nieuw Amsterdam Advisors

United States

NIH

Japan

Nippon Shinyaku Co., Ltd.

United States

Nissan Chemical America Corporation

United States

Nitta Gelatin NA, Inc.

Switzerland

Nodes Advisors AG

United States

North Carolina Biotechnology Center

United States

Novadiscovery

United States

Novatio Ventures

United States

Novo Nordisk A/S - Maaloev

Australia

Novotech

United Kingdom

Nuclera Nucleics Ltd

Australia

Nucleus Network

Sweden

Oblique Therapeutics

United States

Ocugen, Inc.

United States

Oligomerix

United States

OmniAb, Inc.

United Kingdom

One Nucleus

United States

Only Orphans Cote LLC

United States

Ordaos Bio

Japan

Osaka University

United States

Osmol Therapeutics, Inc.

United States

Otsuka-US

United States

Outpace Bio

Canada

Paladin Labs

United States

Palm Therapeutics, Inc.

China

Panacea Venture

Italy

Panakes Partners

Canada

Partner International Inc.

Australia

Patrys Limited

United States

Pepper Bio

Spain

Peptomyc S.L.

South Korea

Peptron Inc.

Israel

PEREGRINE VC

United States

Pharma Capital Partners

United States

PharmaDirections

Taiwan, China

PharmaEngine

United Kingdom

PharmaVentures Ltd

United States

Phyteau

Switzerland

Pictet

United States

Pinetree Therapeutics, Inc

United States

Plum Alley Investments

United States

PMV Pharma

United States

Porcine Preclinical Partners

South Korea

POSVAX

United States

Praxis Bioresearch

United States

PRECIRIX

United States

PrecisionLife

United States

Prime Movers Lab

United States

Profound Ventures

South Korea

Progeneer

Canada

Pullan Consulting

Canada

Qidni Labs

United States

QLD Biotherapeutics Inc

United Kingdom

RBW Consulting

United States

Remiges Ventures

United States

Resurge Therapeutics

United States

ReviveMed

Japan

RevolKa Ltd.

United Kingdom

RSA Consulting

United States

Rubedo Life Sciences

United States

Safi Biotherapeutics

United States

Saghmos Therapeutics, zinc.

South Korea

Samsung Ventures

United States

Sandhill Angels

United States

Santen, Inc.

Japan

Sanwa Kagaku Kenkyusho

Canada

Satellos Bioscience Inc.

Germany

Saventic Health GmbH

United Kingdom

Scendea Ltd

United States

Scioto Biosciences

United States

Senex Biotechnology

United States

Shanghai Henlius Biotech, Inc.

China

Shanghai Jemincare Pharmaceutical Co. Ltd.

China

Shanghai PharmaDeer Co., Ltd

United States

ShareVault

United States

Sherlock Biosciences

United States

Sidereal Therapeutics Inc.

United States

Simcere Pharma

United States

Sinfonia Biotherapeutics

United States

SNIPR Biome

Morocco

SOTHEMA LABORATORIES

Australia

Southern Star Research

United Arab Emirates

Spektar Therapeutics

Switzerland

Spexis Ag

United States

Sprim Global Investments

United States

STAGENEXT

Switzerland

STALICLA SA

United States

StealthCo VC

United States

Sumitomo Pharma America

United States

Sunrise Labs, Inc.

United States

Swiss Business Hub

Taiwan, China

SyneuRx

United Kingdom

SynOx Therapeutics Limited

United States

Taiho Ventures, LLC.

Japan

Takanawa Pharma

United States

Talem Therapeutics

United States

Tanner Pharma Group

Estonia

TBD-Biodiscovery

France

Thabor Therapeutics

India

TheiaLife

United States

Theoria Creative

Finland

TILT Biotherapeutics

Sweden

Toleranzia AB

United States

Torreya Capital

United States

TPOB Consulting LLC

United States

Trade Commission of Spain

United States

Transcenta Therapeutics Inc.

Singapore

Travecta Therapeutics

United States

TrialSpark

China

TYK Medicines, Inc.

Taiwan, China

United BioPharma

United States

USC MESH Academy

Japan

UTokyo Innovation Platform Co. (UTokyo IPC)

Switzerland

Vectura Fertin Pharma

United States

Vedanta Biosciences

Switzerland

Venture Valuation Inc.

United States

Verge Genomics

Denmark

Vesper Bio

United States

Vincerx Pharma

United Kingdom

Viramal Limited

Switzerland

VirdisGroup Sarl

China

VISEN Pharmaceuticals

United States

Viva Bioinnovator

United States

WallachBeth Capital

United States

WellSIM Biotech

United States

Wharton Alumni Angels

United States

Xnergy Financial

Denmark

Xplico ApS

Japan

YAMAHA Motor

United States

YDS Pharmatech, Inc.

United States

Yonjin venture

United States

Yuhan USA

China

Zelgen Biopharmaceuticals

United States

Zmedi

South Korea

Zymedi